See more of our coverage in your search results.Encuentra más de nuestra cobertura en los resultados de búsqueda. Add The New York Times on GoogleAgrega The New York Times en Google At his Senate ...

The Food and Drug Administration has refused to start a review of Moderna's application for its experimental flu shot, the company said. It's another sign of the Trump administration's influence on ...

AstraZeneca reported positive results from a Phase III TULIP-SC clinical trial, showing a statistically significant and clinically meaningful reduction in disease activity with the subcutaneous (SC), ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the self-administered drug formulation in lupus patients with a positive phase ...

SAN FRANCISCO, Dec 11 (Reuters) - A U.S. lawmaker has proposed phasing out Chinese-made sensors in self-driving cars and critical infrastructure amid warnings they could be hacked and disabled from ...

BOSTON--(BUSINESS WIRE)--Corsera Health, Inc., leading the future of cardiovascular health through prediction and prevention, today announced the filing of a clinical trial notification (CTN) to ...

AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that ...

Developed a novel photo-memristor with single-pulse low energy consumption (187 pJ) and multi-pulse linearity up to 0.996. Using photoelectric synaptic characteristics, achieved long-term memory in a ...

Let’s face it: Self-care routines are difficult to establish and maintain. This is true even if we’re fortunate enough to have access to the resources needed, such as wholesome food and time to ...

Abstract: Self-phase modulation (SPM) of gaussian-like pulses induces spectral broadening. This nonlinear effect enables the implementation of post-compression techniques, using a multipass cell (MPC) ...